Chapter Member Anniversaries: January 2019

Posted by ISPE Boston
On February 4, 2019

Please congratulate the following members celebrating milestone anniversaries in January 2019. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years John P. Alleruzzo Kenneth A. Bradley, Pfizer Inc Dr. Eric S. Good, ProPharma Group Dr. Richard C. Moreton, FinnBrit Consulting Jeffery N. Odum, CPIP, Sanofi Genzyme Daniel J. […]

Welcome New Members!

Posted by ISPE Boston
On February 4, 2019

We would like to introduce the Members who joined ISPE in January 2019, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

Call for Presentations Now Open for 2019 Product Show

Posted by ISPE Boston
On January 31, 2019

The ISPE Boston Area Chapter will hold its 28th Annual Product Show on September 18, 2019 at Gillette Stadium in Foxborough, MA. This notice is a call for presentations for a limited number of speaking opportunities. Our charter is to deliver valuable educational programs to our members and their guests, based on specific topics of interest covering […]

Chapter Members Welcome 2019 in Kendall Square

Posted by Mina Jung
On January 31, 2019

The ISPE Boston Area Chapter’s Winter Social at Café ArtScience in the heart of Kendall Square was to feature ice skating, drinks, snacks and plenty of noise. The rain may have prohibited the skating but it didn’t dampen the Chapter’s spirits! We had a FANTASTIC turnout to toast the new year, catch up with friends […]

Future of Pharma Podcast Now Available

Posted by ISPE Boston
On January 29, 2019

The ISPE Boston Area Chapter is excited to announce the launch of The Future of Pharma podcast for our members. Each episode of The Future of Pharma podcast will treat you to an in-depth conversation between the host, Samir Gondalia, and the thought leaders of the pharmaceutical industry. Get a glimpse of where our industry […]

Learn About Advances In Brain Stimulation for Debilitating Brain Diseases

Posted by ISPE Boston
On January 29, 2019

Join MDG Boston on Wednesday, February 6, 5:30-8:30 PM at Regis College in Weston for “Advances in Brain Stimulation – Understanding and Treating Debilitating Brain Diseases.” Recent breakthroughs in data analytics and AI are allowing new insights and treatments for the common brain disorders of mood, cognitive function and movement. This progress results from researching […]

“Single Use Success” Panelists Share End User Wisdom

Posted by Jack Campion
On January 29, 2019

On January 17, EMD Serono in Billerica was the locus for one of the most enthusiastically received programs of the year. The topic was single use technology, a perennial subject of great interest. The panel discussion format featured four of our colleagues from area operating companies, each with valuable firsthand experience of this still-evolving technology. […]

Ironwood and Cyclerion Name Women to Chair Boards

Posted by ISPE Boston
On January 28, 2019

The separation of Ironwood Pharmaceuticals into two independent, publicly traded companies, Ironwood and Cyclerion Therapeutics, first announced in May 2018, is on track to be completed during the first half of 2019; and both companies have named women to lead their new boards of directors. Julie McHugh will serve as chair of the new Ironwood […]

Ironwood, Cyclerion CEOs Named as Split Moves Forward

Posted by ISPE Boston
On January 28, 2019

The separation of Ironwood Pharmaceuticals into two independent, publicly traded companies, first announced in May 2018, is on track to be completed during the first half of 2019. In early January, Ironwood announced the appointment of the CEOs of the two companies, to become effective at the time of the separation. Industry veteran Mark Mallon […]

Kyn Therapeutics and Celgene to Develop Immuno-oncology Therapies

Posted by ISPE Boston
On January 25, 2019

Kyn Therapeutics, a Boston-based, clinical-stage biotech launched in December 2017 has announced a global strategic collaboration with Celgene to develop novel immuno-oncology therapies. The collaboration unites Kyn’s immuno-oncology expertise and pipeline with Celgene’s capabilities for developing and commercializing medicines in areas of high unmet medical need. It gives Celgene exclusive options to license Kyn’s aryl […]

Page 87 of 117«‹85 868788 89 ›»